Results 121 to 130 of about 134,783 (292)

PATHOMORPHOLOGICAL FEATURES DIAGNOSTIC OF THE OSTEOSARCOMA IN DOGS

Ветеринарная патология, 2013
Bone tumor are characterized by an aggressive course, early hematogenous metastasis. The incidence of canine osteosarcoma is 80 - 90 % of bone tumors. The main method in diagnosis of osteosarcoma is morphological.
Natalya Viktorovna Mitrokhina, Yuriy Anatolyevich Vatnikov   +1 more
doaj  

Targeting the mitochondrial protein YME1L to inhibit osteosarcoma cell growth in vitro and in vivo

Cell Death and Disease
Exploring novel diagnostic and therapeutic biomarkers is extremely important for osteosarcoma. YME1 Like 1 ATPase (YME1L), locating in the mitochondrial inner membrane, is key in regulating mitochondrial plasticity and metabolic activity.
Xu Sun, Ce Shi, Jin Dai, Mei-Qing Zhang, Dong-Sheng Pei, Lei Yang   +5 more
doaj   +1 more source

The activities of Smad and Gli mediated signalling pathways in high-grade conventional osteosarcoma [PDF]

, 2012
Alexander B. Mohseny, Yongping Cai, Marieke L. Kuijjer, Wei Xiao, Brendy van den Akker, Carlos E. de Andrea, Rutger J. Jacobs, Peter ten Dijke, Pancras C.W. Hogendoorn, Anne‐Marie Cleton-Jansen   +9 more
openalex   +1 more source

Reprogramming tumor immune microenvironment by ultrasound‐responsive nanoplatforms for enhanced cancer immunotherapy

BMEMat, EarlyView.
Ultrasound‐responsive nanoplatforms reprogram the tumor immune microenvironment by targeting tumor cells, immune cells, and non‐immune stromal cells to enhance the efficacy of cancer immunotherapy. Abstract Cancer immunotherapy represents a significant advancement in cancer treatment by enhancing the specific recognition and elimination of cancer cells.
Shilong Zhao, Rui Qu, Zan Dai, Xiqun Jiang, Xu Zhen   +4 more
wiley   +1 more source

Downregulation of TMTC4 expression is associated with improved prognosis in osteosarcoma

Journal of International Medical Research
Purpose Osteosarcoma is the most common primary tumor of bone tissue. To date, the expression of transmembrane and tetratricopeptide repeat containing 4 (TMTC4) in osteosarcoma has not been reported.
Zihan Li, Yihao Tian
doaj   +1 more source

Osteosarcoma [PDF]

British Journal of Cancer, 2001
Philip, T, Blay, J Y, Brunat-Mentigny, M, Carrie, C, Chauvot, P, Farsi, F, Fervers, B, Gentet, J C, Giammarile, F, Kohler, R, Mathoulin, S, Patricot, L M, Thiesse, P   +12 more
openaire   +2 more sources

Pt‐TiO2 mesoporous nanosystem co‐delivering phlorezin enables synergistic sonodynamic‐chemoimmunotherapy for hepatocellular carcinoma via directly targeting DDX5 and metabolic reprogramming modulation

BMEMat, EarlyView.
Abstract Hepatocellular carcinoma (HCC), ranking as the third leading cause of cancer‐related mortality globally, continues to pose significant therapeutic challenges. Here, we developed an innovative nanosystem, Phl@PT, based on Pt‐TiO2 nanoparticles for the co‐delivery of Phlorezin, presenting a novel approach for HCC treatment through sonodynamic ...
Kairui Liu, Bo Zhang, Yue Wan, Zhiru Yang, Abdusami Abdurahman, Mengxin He, Shengtao Hu, Yi Zhang, Xiaoke Li, Jin Chang, Jun Kang, Liren Liu, Wanghua Liu, Shao Li   +13 more
wiley   +1 more source

Partial replacement of pelvis with the hip joint in osteosarcoma treatment: A case report

, 2021
Dũng Trần Trung, Sang Nguyen Tran Quang, Hieu Pham Trung, Vu Tu Nam, Nang Vo Sy Quyen, Thanh Tran Duc, Nguyễn Tiến Dũng, Trần Thiết Sơn, Phạm Thị Việt Dung, Nguyễn Văn Trưởng   +9 more
openalex   +1 more source

Boron Neutron Capture Therapy at a Crossroads: Translational Gap and Emerging Delivery Agents

Chemistry – A European Journal, EarlyView.
This review surveys recent advances in boron delivery agents for BNCT, emphasizing the shift from classical small molecules to multifunctional nanocarriers and theranostic systems. By integrating targeting, imaging, and therapy, next‐generation boron compounds aim to bridge the gap between (bio)chemical innovation and clinical translation.
Christoph Selg, Evamarie Hey‐Hawkins
wiley   +1 more source

Carbon Dots for Cancer Theranostics: Synthesis Strategies, Luminescence Properties, and Advances in Bioimaging‐Guided Diagnosis and Therapy

Chemistry – A European Journal, EarlyView.
Lighting up the path to precision oncology: This review comprehensively summarizes the rational design of carbon dots (CDs), elucidating how core size, surface chemistry, and heteroatom doping dictate their luminescence mechanisms. Special emphasis is placed on engineering NIR‐II emissive CDs for deep‐tissue imaging.
Zekun Yan, Yupeng Liu, Jinyun Tan, Songnan Qu   +3 more
wiley   +1 more source